- Home
- SCNX vs NXPL Comparison
SCNX vs NXPL Comparison
Compare SCNX & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCNX
- NXPL
- Stock Information
- Founded
- SCNX 2010
- NXPL 1997
- Country
- SCNX United States
- NXPL United States
- Employees
- SCNX N/A
- NXPL N/A
- Industry
- SCNX Other Pharmaceuticals
- NXPL Telecommunications Equipment
- Sector
- SCNX Health Care
- NXPL Telecommunications
- Exchange
- SCNX Nasdaq
- NXPL Nasdaq
- Market Cap
- SCNX 21.2M
- NXPL 22.8M
- IPO Year
- SCNX 2020
- NXPL N/A
- Fundamental
- Price
- SCNX $0.80
- NXPL $0.80
- Analyst Decision
- SCNX
- NXPL
- Analyst Count
- SCNX 0
- NXPL 0
- Target Price
- SCNX N/A
- NXPL N/A
- AVG Volume (30 Days)
- SCNX 409.9K
- NXPL 282.9K
- Earning Date
- SCNX 11-05-2025
- NXPL 11-13-2025
- Dividend Yield
- SCNX N/A
- NXPL N/A
- EPS Growth
- SCNX N/A
- NXPL N/A
- EPS
- SCNX N/A
- NXPL N/A
- Revenue
- SCNX $128,202.00
- NXPL $58,766,000.00
- Revenue This Year
- SCNX N/A
- NXPL N/A
- Revenue Next Year
- SCNX N/A
- NXPL N/A
- P/E Ratio
- SCNX N/A
- NXPL N/A
- Revenue Growth
- SCNX N/A
- NXPL N/A
- 52 Week Low
- SCNX $0.69
- NXPL $0.43
- 52 Week High
- SCNX $9.55
- NXPL $2.30
- Technical
- Relative Strength Index (RSI)
- SCNX 32.58
- NXPL 50.29
- Support Level
- SCNX $0.81
- NXPL $0.77
- Resistance Level
- SCNX $0.89
- NXPL $0.86
- Average True Range (ATR)
- SCNX 0.05
- NXPL 0.06
- MACD
- SCNX 0.02
- NXPL -0.00
- Stochastic Oscillator
- SCNX 23.87
- NXPL 15.47
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.
About NXPL NextPlat Corp
NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.